These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 37016694)
1. Mitigating the economic burden of GnRH agonist therapy for progestogen-resistant endometriosis: why not? Vercellini P; Bandini V; Buggio L; Barbara G; Berlanda N; Dridi D; Frattaruolo MP; Somigliana E Hum Reprod Open; 2023; 2023(2):hoad008. PubMed ID: 37016694 [TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
3. The ultra-long study: a randomized controlled trial evaluating long-term GnRH downregulation prior to ART in women with endometriosis. Tomassetti C; Beukeleirs T; Conforti A; Debrock S; Peeraer K; Meuleman C; D'Hooghe T Hum Reprod; 2021 Sep; 36(10):2676-2686. PubMed ID: 34370858 [TBL] [Abstract][Full Text] [Related]
4. Fertility preservation for women with breast cancer: a multicentre randomized controlled trial on various ovarian stimulation protocols. Balkenende EME; Dahhan T; Beerendonk CCM; Fleischer K; Stoop D; Bos AME; Lambalk CB; Schats R; Smeenk JMJ; Louwé LA; Cantineau AEP; de Bruin JP; Linn SC; van der Veen F; van Wely M; Goddijn M Hum Reprod; 2022 Jul; 37(8):1786-1794. PubMed ID: 35776109 [TBL] [Abstract][Full Text] [Related]
5. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis. van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL; Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350 [TBL] [Abstract][Full Text] [Related]
6. Medical treatment or surgery for colorectal endometriosis? Results of a shared decision-making approach. Vercellini P; Frattaruolo MP; Rosati R; Dridi D; Roberto A; Mosconi P; De Giorgi O; Cribiù FM; Somigliana E Hum Reprod; 2018 Feb; 33(2):202-211. PubMed ID: 29228373 [TBL] [Abstract][Full Text] [Related]
7. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol. Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B; Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013 [TBL] [Abstract][Full Text] [Related]
8. Müllerian anomalies and endometriosis as potential explanatory models for the retrograde menstruation/implantation and the embryonic remnants/celomic metaplasia pathogenic theories: a systematic review and meta-analysis. Vercellini P; Salmeri N; Somigliana E; Piccini M; Caprara F; Viganò P; De Matteis S Hum Reprod; 2024 May; ():. PubMed ID: 38733102 [TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of ASP1707 for endometriosis-associated pelvic pain: the phase II randomized controlled TERRA study. D'Hooghe T; Fukaya T; Osuga Y; Besuyen R; López B; Holtkamp GM; Miyazaki K; Skillern L Hum Reprod; 2019 May; 34(5):813-823. PubMed ID: 31067329 [TBL] [Abstract][Full Text] [Related]
10. Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Kang JL; Wang XX; Nie ML; Huang XH Gynecol Obstet Invest; 2010; 69(2):73-7. PubMed ID: 19923847 [TBL] [Abstract][Full Text] [Related]
11. Is a freeze-all policy the optimal solution to circumvent the effect of late follicular elevated progesterone? A multicentric matched-control retrospective study analysing cumulative live birth rate in 942 non-elective freeze-all cycles. Racca A; Vanni VS; Somigliana E; Reschini M; Viganò P; Santos-Ribeiro S; Drakopoulos P; Tournaye H; Verheyen G; Papaleo E; Candiani M; Blockeel C Hum Reprod; 2021 Aug; 36(9):2463-2472. PubMed ID: 34223890 [TBL] [Abstract][Full Text] [Related]
12. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze). Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830 [TBL] [Abstract][Full Text] [Related]
13. The depot GnRH agonist protocol improves the live birth rate per fresh embryo transfer cycle, but not the cumulative live birth rate in normal responders: a randomized controlled trial and molecular mechanism study. Xu B; Geerts D; Hu S; Yue J; Li Z; Zhu G; Jin L Hum Reprod; 2020 Jun; 35(6):1306-1318. PubMed ID: 32478400 [TBL] [Abstract][Full Text] [Related]
14. A drop in serum progesterone from oocyte pick-up +3 days to +5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates. Uyanik E; Mumusoglu S; Polat M; Yarali Ozbek I; Esteves SC; Humaidan P; Yarali H Hum Reprod; 2023 Feb; 38(2):225-236. PubMed ID: 36478179 [TBL] [Abstract][Full Text] [Related]
15. Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial. Hamdine O; Macklon NS; Eijkemans MJ; Laven JS; Cohlen BJ; Verhoeff A; van Dop PA; Bernardus RE; Lambalk CB; Oosterhuis GJ; Holleboom CA; van den Dool-Maasland GC; Verburg HJ; van der Heijden PF; Blankhart A; Fauser BC; Broekmans FJ; Hum Reprod; 2013 Dec; 28(12):3227-35. PubMed ID: 24129613 [TBL] [Abstract][Full Text] [Related]
16. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles. Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174 [TBL] [Abstract][Full Text] [Related]
17. Is retrograde menstruation a universal, recurrent, physiological phenomenon? A systematic review of the evidence in humans and non-human primates. Viganò P; Caprara F; Giola F; Di Stefano G; Somigliana E; Vercellini P Hum Reprod Open; 2024; 2024(3):hoae045. PubMed ID: 39055487 [TBL] [Abstract][Full Text] [Related]
18. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder. Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL; Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269 [TBL] [Abstract][Full Text] [Related]
19. The rate of euploid miscarriage is increased in the setting of adenomyosis. Stanekova V; Woodman RJ; Tremellen K Hum Reprod Open; 2018; 2018(3):hoy011. PubMed ID: 30895252 [TBL] [Abstract][Full Text] [Related]
20. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial. Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]